Back to search
Long QT Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Long QT Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Long QT Syndrome trials you may qualify forThe goal of this observational study is to develop a registry of Brazilian patients with hereditary cardiovascular diseases, combining clinical and genomic data…
The goal of this prospective population-based study is to evaluate the new disease description and management guidelines for breath-holding spells in children (…
An important aspect of successful genomic medicine implementation is developing effective approaches for screening at-risk family members after probands are ide…
The goal of this clinical trial is to learn whether the study drug THRV-1268 can safely and effectively shorten the QT interval in people diagnosed with Long QT…
Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common…
There are 28 non-cardiology medications from multiple families costing more than $13 billion annually in Canada, categorized as 'Known' QT-prolonging medication…
GM508 CultActive is a bicarbonate buffered reagent and ready-to-use designed to investigate oocytes of patients with failed fertilization after previous Intracy…
This research will determine if: 1) Oral progesterone attenuates drug-induced QT interval, J-Tpeak and Tpeak-Tend lengthening in postmenopausal women 50 years o…
This is a randomized, prospective clinical trial comparing 2 different types of implantable cardioverter defibrillator (ICD) leads in children and patients with…